NCT00569530 - Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction)Bronchopulmonary Dysplasia

Interventions

DRUG

Infasurf (ONY Inc.)

Infasurf 3ml/kg will be given to infants on study days 0, 3, 7, 10, and 14, if remains intubated.

DRUG

Sham

Sham instillation (no treatment) will be given to study infants on days 0, 3, 7, 10, and 14, if remains intubated.

Trial Locations (9)

Stony Brook University Medical Center, Stony Brook

Women and Children's Hospital of Buffalo, Buffalo

Northwestern Memorial Hospital, Chicago

Children's Memorial Hospital, Chicago

Children's Mercy Hospital, Kansas City

Texas Children's Hospital, Houston

University of California, San Francisco, San Francisco

Children's Hospital Oakland, Oakland

Alta Bates Summit Medical Center, Berkeley